Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-04-08 | 2022-06-17 | 158428 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-04-21 | 2022-06-03 | 159204 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-09-07 | 2022-10-01 | 168737 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184207 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194131 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195487 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199387 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2024-09-19 | 2024-11-08 | 237977 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2020-07-23 | 2020-09-17 | 120884 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2020-11-19 | 2021-01-21 | 128632 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1038 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1137 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-07-18 | 2023-08-18 | 199026 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-08-17 | 2023-10-03 | 202246 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-10-05 | 2023-11-30 | 206380 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-30 | 207515 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2022-12-22 | 2023-02-16 | 179191 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184916 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2022-08-18 | 2022-12-02 | 167251 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |